Characterization of fibroblast growth factor 1 binding heparan sulfate domain.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 10362842)

Published in Glycobiology on July 01, 1999

Authors

J Kreuger1, K Prydz, R F Pettersson, U Lindahl, M Salmivirta

Author Affiliations

1: Department of Medical Biochemistry and Microbiology, Uppsala University, S-75123, Uppsala, Sweden.

Articles citing this

Fibroblast growth factors share binding sites in heparan sulphate. Biochem J (2005) 1.15

Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow. Anal Chem (2010) 1.14

Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc Natl Acad Sci U S A (2000) 1.07

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J (2002) 1.07

Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling. J Biol Chem (2010) 1.06

Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry. Biochemistry (2008) 1.04

'Heparin'--from anticoagulant drug into the new biology. Glycoconj J (2001) 1.01

Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry. Biochemistry (2010) 0.92

Heparan sulfate and heparin interactions with proteins. J R Soc Interface (2015) 0.83

Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Pigment Cell Melanoma Res (2014) 0.80

Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation. J Neurosci (2012) 0.80

Solid-Phase Synthesis of 2-Aminoethyl Glucosamine Sulfoforms. J Carbohydr Chem (2012) 0.77

Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study. J Am Soc Mass Spectrom (2016) 0.75

Articles by these authors

Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53

Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40

Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem (1978) 4.51

Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res (1991) 3.16

5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00

A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A (1992) 2.92

Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A (1996) 2.71

Endocytosis in filter-grown Madin-Darby canine kidney cells. J Cell Biol (1989) 2.65

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci U S A (1980) 2.61

Identification of a protein linked to nascent poliovirus RNA and to the polyuridylic acid of negative-strand RNA. J Virol (1978) 2.54

Amino acid sequence of alpha-amylase from Bacillus amyloliquefaciens deduced from the nucleotide sequence of the cloned gene. J Biol Chem (1983) 2.54

Bunyaviridae. Intervirology (1980) 2.53

Meeting of the apical and basolateral endocytic pathways of the Madin-Darby canine kidney cell in late endosomes. J Cell Biol (1989) 2.51

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 2.49

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem (1998) 2.47

Ribonucleoproteins of Uukuniemi virus are circular. J Virol (1975) 2.37

Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34

Heparan sulfate: a piece of information. FASEB J (1996) 2.33

18S defective interfering RNA of Semliki Forest virus contains a triplicated linear repeat. Proc Natl Acad Sci U S A (1981) 2.32

Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens. Gene (1981) 2.30

Biosynthesis of heparin. II. Formation of sulfamino groups. J Biol Chem (1973) 2.27

Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem (1993) 2.23

Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b. J Virol (1983) 2.19

A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18

Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci U S A (1979) 2.08

Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem (1993) 2.07

The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J (1978) 2.03

Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem (1998) 1.93

Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem (2001) 1.89

Heparin-lipoprotein lipase interactions. Fed Proc (1977) 1.87

Domain structure of heparan sulfates from bovine organs. J Biol Chem (1996) 1.84

Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res (1982) 1.83

Mechanism of the anticoagulant action of heparin. Mol Cell Biochem (1982) 1.80

Uukuniemi virus maturation: accumulation of virus particles and viral antigens in the Golgi complex. Mol Cell Biol (1982) 1.80

Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs. J Virol (2001) 1.80

The genome of Uukuniemi virus consists of three unique RNA segments. Cell (1977) 1.78

An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5' terminal protein. Cell (1978) 1.69

Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem (2001) 1.68

Circular forms of Uukuniemi virion RNA: an electron microscopic study. J Virol (1977) 1.67

Induced expression of syndecan in healing wounds. J Cell Biol (1991) 1.67

Ricin transport in brefeldin A-treated cells: correlation between Golgi structure and toxic effect. J Cell Biol (1991) 1.64

In vitro translation of Uukuniemi virus-specific RNAs: identification of a nonstructural protein and a precursor to the membrane glycoproteins. J Virol (1981) 1.63

The remaining stocks of smallpox virus should be destroyed. Science (1993) 1.62

Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate. Biochem J (1974) 1.59

Formation and intracellular transport of a heterodimeric viral spike protein complex. J Cell Biol (1991) 1.58

Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57

Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem (1984) 1.56

The chondroitin 4-sulfate-protein linkage. J Biol Chem (1966) 1.55

Attempted isolation of a heparin proteoglycan from bovine liver capsule. Biochem J (1970) 1.53

Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem (1979) 1.53

Complete nucleotide sequence of the M RNA segment of Uukuniemi virus encoding the membrane glycoproteins G1 and G2. Virology (1987) 1.51

Extreme ends of the genome are conserved and rearranged in the defective interfering RNAs of Semliki Forest virus. J Mol Biol (1982) 1.51

Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins. J Virol (1984) 1.51

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J (1984) 1.49

Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49

Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem (1998) 1.47

Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus. J Virol (1991) 1.47

Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem (1984) 1.46

Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Biochem J (1979) 1.44

Uukuniemi virus contains an RNA polymerase. J Virol (1975) 1.44

Further characterization of the heparin-protein linkage region. Biochim Biophys Acta (1966) 1.44

Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem (1999) 1.42

The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep (2000) 1.41

Uukuniemi virus maturation: immunofluorescence microscopy with monoclonal glycoprotein-specific antibodies. J Virol (1984) 1.40

Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J Biol Chem (1980) 1.38

Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem (1987) 1.38

Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J (1999) 1.38

N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Anal Biochem (1982) 1.37

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J Biol Chem (1997) 1.35

Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J (1980) 1.33

Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J Biol Chem (1975) 1.32

Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun (1971) 1.32

Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc Natl Acad Sci U S A (2008) 1.31

pH-induced microtubule-dependent redistribution of late endosomes in neuronal and epithelial cells. J Cell Biol (1991) 1.31

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem (2000) 1.31

Identification of iduronic acid as the major sulfated uronic acid of heparin. J Biol Chem (1971) 1.30

A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein. J Virol (1997) 1.30

Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30

Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ (2000) 1.29

Uukuniemi virus S RNA segment: ambisense coding strategy, packaging of complementary strands into virions, and homology to members of the genus Phlebovirus. J Virol (1990) 1.27

5'-Terminal nucleotide sequence of Semliki forest virus 18S defective interfering RNA is heterogeneous and different from the genomic 42S RNA. Proc Natl Acad Sci U S A (1981) 1.27

The nucleotide sequences of the 5'-terminal T1 oligonucleotides of Semliki-Forest-virus 42-S and 26-S RNAs are different. Eur J Biochem (1980) 1.27

Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis. Proc Natl Acad Sci U S A (2001) 1.26

Nucleotide sequence of the genes coding for the membrane glycoproteins E1 and E2 of rubella virus. J Gen Virol (1987) 1.26

Anticoagulant activity of heparin: isolation of antithrombin-binding sites. FEBS Lett (1976) 1.26

Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J (1988) 1.26

Biosynthesis of L-iduronic acid in heparin: epimerization of D-glucuronic acid on the polymer level. Biochem Biophys Res Commun (1972) 1.25

Chemical synthesis and molecular cloning of a STOP oligonucleotide encoding an UGA translation terminator in all three reading frames. Gene (1983) 1.24

The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J Biol Chem (1983) 1.24

Molecular cloning and expression of a 58-kDa cis-Golgi and intermediate compartment protein. J Biol Chem (1996) 1.24

The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length. FEBS Lett (1989) 1.23

Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells. J Biol Chem (1985) 1.23

Biosynthesis of heparan sulfate. Coordination of polymer-modification reactions in a Chinese hamster ovary cell mutant defective in N-sulfotransferase. J Biol Chem (1991) 1.23

Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry (2001) 1.22

The coxsackie-adenovirus receptor--a new receptor in the immunoglobulin family involved in cell adhesion. Curr Top Microbiol Immunol (2004) 1.22